Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Hims and Hers (HIMS) PT Raised to $24 at Citi
November 5, 2024 6:31 AM ESTCiti analyst Daniel Grosslight raised the price target on Hims and Hers (NYSE: HIMS) to $24.00 (from $20.00) while maintaining a Neutral rating.
The analyst comments "HIMS results continue to impress, with another significant beat-and-raise across the board (LINK). Given much of this outperformance was... More
